Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tara Fehlmann"'
Autor:
Andres Yarur, Freddy Caldera, Sirimon O'Charoen, Joshua R. Korzenik, Cecile Norris, Matthew Bohm, Monika Fischer, Sara Sweeney, Alandra Weaver, Uni Wong, Sushila Dalal, Themistocles Dassopoulos, Katerina Wells, David Hudesman, Lilani P. Perera, Shrinivas Bishu, Caren Heller, Richard H. Duerr, Tara Fehlmann, Deepak Parakkal, Raymond K. Cross, James D. Lewis, Manreet Kaur, Matthew A. Ciorba, Sumona Saha, Elizabeth A. Scoville, Laura E. Raffals, Joel Pekow, Scott B. Snapper, Angela Dobes, Meenakshi Bewtra
Publikováno v:
Inflamm Bowel Dis
Background Clinical and molecular subcategories of inflammatory bowel disease (IBD) are needed to discover mechanisms of disease and predictors of response and disease relapse. We aimed to develop a study of a prospective adult research cohort with I
Autor:
Luke Liu, Sirimon O'Charoen, Tara Fehlmann, Silke Roedder, Emily Wendt, Andrew Billin, Islam Younis, Shahed Iqbal
Publikováno v:
Gastroenterology. 164:S42
OBJECTIVE Benefit of antibiotic use in Inflammatory Bowel Disease (IBD) is unclear and has been a subject of research. This study investigated the association between antibiotic use and treatment outcomes among IBD patients using real-world data. MET
Autor:
Tara Fehlmann, Matthew B. Yurgelun, C. Sloane Furniss, Chinedu Ukaegbu, Hajime Uno, Alessandro Mannucci, Sapna Syngal, Miki Horiguchi
Publikováno v:
Journal of Clinical Oncology. 38:4086-4094
PURPOSE Tumor testing for microsatellite instability and/or mismatch repair-deficiency (MSI/IHC) and clinical prediction models effectively screen for Lynch syndrome (LS)–associated colorectal cancer (CRC) and endometrial cancer (EC), but they have
Publikováno v:
Inflammatory Bowel Diseases. 29:S23-S23
OBJECTIVE IBD Plexus is a data exchange platform that houses four cohorts, including The Study of a Prospective Adult Research Cohort with IBD (SPARC IBD). SPARC IBD is a multicentered, longitudinal cohort that follows patients through their standard
Autor:
Sapna Syngal, J. Reyes, Rosa M. Xicola, S. P. Ortega, Junrui Wang, S. De Leon, Xavier Llor, Nathan A. Ellis, Joann B. Sweasy, Mar Giner-Calabuig, Tara Fehlmann, Chinedu Ukaegbu, Marta Carrillo-Palau, Maite Herraiz, Elena M. Stoffel, Rodrigo Jover, M. Cecchini, C. Alenda, M. Alustiza Fernandez, María Dolores Picó, Joanna Gibson, Inmaculada Salces, A. Obrador
BackgroundMismatch repair (MMR) deficiency is the hallmark of tumors from Lynch syndrome (LS), sporadic MLH1 hypermethylated, and Lynch-like syndrome (LLS), but there is a lack of understanding of the variability in their mutational profiles based on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::950697fdb18470fc0d51796bf169fcd9
https://doi.org/10.1101/2021.09.28.460630
https://doi.org/10.1101/2021.09.28.460630
Autor:
Alessandro, Mannucci, C Sloane, Furniss, Chinedu, Ukaegbu, Miki, Horiguchi, Tara, Fehlmann, Hajime, Uno, Matthew B, Yurgelun, Sapna, Syngal
Publikováno v:
J Clin Oncol
PURPOSE: Tumor testing for microsatellite instability and/or mismatch repair-deficiency (MSI/IHC) and clinical prediction models effectively screen for Lynch syndrome (LS)–associated colorectal cancer (CRC) and endometrial cancer (EC), but they hav
Autor:
Shilpa Grover, Fay Kastrinos, Hajime Uno, Anu Chittenden, Tara Fehlmann, Chinedu Ukaegbu, Matthew B. Yurgelun, Jennifer A. Inra, Sapna Syngal, Zohar Levi
Publikováno v:
Fam Cancer
BACKGROUND: Germline variants in the APC and MUTYH genes contribute to colorectal cancer (CRC) and adenoma risk, though may occur with varying frequencies in individuals of different ancestries. The aim of this study was to evaluate the prevalence of
Autor:
Matthew B. Yurgelun, Chinedu Ukaegbu, Miki Horiguchi, Judy Garber, Tara Fehlmann, C. Sloane Furniss, Anu Chittenden, Holly LaDuca, Amal Yussuf, Hajime Uno, Sapna Syngal
Publikováno v:
Journal of Clinical Oncology. 38:1579-1579
1579 Background: Current clinical prediction models provide syndrome-specific numeric estimates of an individual's likelihood of having a specific hereditary cancer syndrome (e.g., PREMM5 for Lynch syndrome; BRCAPRO for BRCA1/2). With the emergence o